Directing the biological activities of heparan sulfate oligosaccharides using a chemoenzymatic approach

被引:18
|
作者
Xu, Yongmei [2 ]
Wang, Zhen [3 ]
Liu, Renpeng [2 ]
Bridges, Arlene S. [3 ]
Huang, Xuefei [1 ]
Liu, Jian [2 ]
机构
[1] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA
[2] Univ N Carolina, Eshelman Sch Pharm, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Sch Med, Dept Pathol, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
antithrombin; FGF; heparan sulfate; oligosaccharides; sulfotransferases; COMPOSITIONAL ANALYSIS; CRYSTAL-STRUCTURE; BINDING SITE; GLYCOSAMINOGLYCANS; DISACCHARIDE; INHIBITION; PROTEINS; DESIGN; CODE;
D O I
10.1093/glycob/cwr109
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heparan sulfate (HS) and heparin are highly sulfated polysaccharides exhibiting essential physiological functions. The sulfation patterns determine the functional selectivity for HS and heparin. Chemical synthesis of HS, especially those larger than a hexasaccharide, remains challenging. Enzymatic synthesis of HS has recently gained momentum. Here we describe the divergent assembly of HS heptasaccharides and nonasaccharides from a common hexasaccharide precursor. The hexasaccharide precursor was synthesized via a chemical method. The subsequent elongation, sulfation and epimerization were completed by glycosyltransferases, HS sulfotransferases and epimerase. Using the synthesized heptasaccharides, we discovered that the iduronic acid is critical for binding to fibroblast growth factor-2. We also designed a synthetic path to prepare a nonasaccharide with an antithrombin-binding affinity of 3 nM. Our method demonstrated the feasibility of combining chemical and enzymatic synthesis to prepare structurally defined HS oligosaccharides with desired biological activities.
引用
收藏
页码:96 / 106
页数:11
相关论文
共 50 条
  • [41] Distribution of Heparan Sulfate Oligosaccharides in Murine Mucopolysaccharidosis Type IIIA
    Mason, Kerryn
    Meikle, Peter
    Hopwood, John
    Fuller, Maria
    METABOLITES, 2014, 4 (04) : 1088 - 1100
  • [42] Electrophoretic sequencing of heparin/heparan sulfate oligosaccharides using a highly sensitive fluorescent end label
    Drummond, KJ
    Yates, EA
    Turnbull, JE
    PROTEOMICS, 2001, 1 (02) : 304 - 310
  • [43] Chemoenzymatic synthesis of classical and non-classical anticoagulant heparan sulfate polysaccharides
    Kuberan, B
    Beeler, DL
    Lech, M
    Wu, ZLL
    Rosenberg, RD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (52) : 52613 - 52621
  • [44] BIOLOGICAL SIGNIFICANCE OF HEPARAN-SULFATE PROTEOGLYCANS
    BUONASSISI, V
    COLBURN, P
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1982, 401 (DEC) : 76 - 84
  • [45] Structure and biological interactions of heparin and heparan sulfate
    Casu, B
    Lindahl, U
    ADVANCES IN CARBOHYDRATE CHEMISTRY AND BIOCHEMISTRY, VOL 57, 2001, 57 : 159 - 206
  • [46] Biological role of heparan sulfate in osteogenesis: A review
    Xu, Zhujie
    Chen, Shayang
    Feng, Dehong
    Liu, Yi
    Wang, Qiqi
    Gao, Tianshu
    Liu, Zhenwei
    Zhang, Yan
    Chen, Jinghua
    Qiu, Lipeng
    CARBOHYDRATE POLYMERS, 2021, 272
  • [47] Targeting heparan sulfate-protein interactions with oligosaccharides and monoclonal antibodies
    Li, Miaomiao
    Pedersen, Lars C.
    Xu, Ding
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [48] Strategies in Synthesis of Heparin/Heparan Sulfate Oligosaccharides: 2000-Present
    Dulaney, Steven B.
    Huang, Xuefei
    ADVANCES IN CARBOHYDRATE CHEMISTRY AND BIOCHEMISTRY, VOL 80, 2021, 80 : 121 - 164
  • [49] Preclinical development of heparan sulfate oligosaccharides for drug induced liver injury
    Arnold, Katelyn
    Xu, Yongmei
    Yin, Chaoying
    Wang, Zhangjie
    Liu, Jian
    GLYCOBIOLOGY, 2023, 33 (11) : 1054 - 1055
  • [50] Preparation and structure of heparin lyase-derived heparan sulfate oligosaccharides
    Hileman, RE
    Smith, AE
    Toida, T
    Linhardt, RJ
    GLYCOBIOLOGY, 1997, 7 (02) : 231 - 239